{"transactions":[{"id":4639761,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-13T22:11:36.000Z","date":"2026-10-13","kind":"grant","planned":false,"acquired":true,"shares":5636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on the first anniversary of the date of grant, with the remaining stock options vesting in 12 quarterly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option award granted pursuant to the Issuer's 2026 Equity Incentive Plan. Twenty-five percent of the stock option vests on the first anniversary of the date of grant, with the remaining stock options vesting in 12 quarterly increments thereafter, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":5636,"derivative":{"exercise_price":11.63,"expiration_date":"2036-10-13","underlying":"Common Stock","underlying_shares":5636},"source":{"system":"sec-edgar","filing":"0001213900-26-109157","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002988/000121390026109157/ownership.xml","form_type":"4"}},{"id":2478993,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-12-09T23:31:14.000Z","date":"2021-12-08","kind":"disposition_to_issuer","acquired":false,"shares":37567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on April 15, 2021 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the shares of common stock underlying the remaining restricted stock units vest on April 15, 2022 and the remainder vest on April 15, 2023, subject to the Reporting Person providing continuous service to the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the shares of common stock underlying the remaining restricted stock units vest on April 15, 2022 and the remainder vest on April 15, 2023, subject to the Reporting Person providing continuous service to the Issuer through each such date."}],"balance_after":75133,"derivative":{"underlying":"Common Stock","underlying_shares":37567},"source":{"system":"sec-edgar","filing":"0001636050-21-000098","document":"wf-form4_163909265726806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000163605021000098/wf-form4_163909265726806.xml","form_type":"4"}},{"id":2478992,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-09T23:31:14.000Z","date":"2021-12-08","kind":"tax_withholding","acquired":false,"shares":14884,"price":1.42,"value":21135.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold on behalf of the Reporting Person in the open market to cover withholding taxes relating to the settlement of the vested restricted stock units."}],"balance_after":203109,"source":{"system":"sec-edgar","filing":"0001636050-21-000098","document":"wf-form4_163909265726806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000163605021000098/wf-form4_163909265726806.xml","form_type":"4"}},{"id":2478991,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-09T23:31:14.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":37567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":217993,"source":{"system":"sec-edgar","filing":"0001636050-21-000098","document":"wf-form4_163909265726806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000163605021000098/wf-form4_163909265726806.xml","form_type":"4"}},{"id":2745227,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T20:51:56.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":682100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of three years with one-third of the shares of common stock underlying the option vesting on April 15, 2022 and the remainder vesting in 8 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested shares of common stock. All shares of common stock underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's Amended and Restated 2015 Equity Incentive Plan."}],"balance_after":682100,"derivative":{"exercise_price":2.47,"expiration_date":"2031-04-14","underlying":"Common Stock","underlying_shares":682100},"source":{"system":"sec-edgar","filing":"0001636050-21-000044","document":"wf-form4_161886549794518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000163605021000044/wf-form4_161886549794518.xml","form_type":"4"}},{"id":2773232,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-24T23:21:43.000Z","date":"2021-03-23","kind":"purchase","acquired":true,"shares":100000,"price":2.4818,"value":248180.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.50 per share, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote."}],"balance_after":180426,"source":{"system":"sec-edgar","filing":"0001636050-21-000033","document":"wf-form4_161662808813010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000163605021000033/wf-form4_161662808813010.xml","form_type":"4"}},{"id":2777693,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-19T20:55:49.000Z","date":"2021-03-17","kind":"disposition_to_issuer","acquired":false,"shares":22590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. The shares of common stock underlying the restricted stock units vested on July 31, 2020 but settlement of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22590},"source":{"system":"sec-edgar","filing":"0001636050-21-000027","document":"wf-form4_161618733299469.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000163605021000027/wf-form4_161618733299469.xml","form_type":"4"}},{"id":2777692,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-19T20:55:49.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":22590,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80426,"source":{"system":"sec-edgar","filing":"0001636050-21-000027","document":"wf-form4_161618733299469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000163605021000027/wf-form4_161618733299469.xml","form_type":"4"}},{"id":3084993,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Common Shares","published_at":"2020-07-10T22:11:07.000Z","date":"2020-07-08","kind":"purchase","acquired":true,"shares":37500,"price":2.737,"value":102637.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The purchases reported in this Form 4 were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the sales of shares by the reporting person at $3.09 per share on June 11, 2020.  The reporting person has paid to the Issuer the $3,616.37 loss avoided by the reporting person in connection with the short-swing transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.70 to $2.79 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote."}],"balance_after":57836,"source":{"system":"sec-edgar","filing":"0001209191-20-042215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919120042215/doc4.xml","form_type":"4"}},{"id":3110668,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-15T23:39:27.000Z","date":"2020-06-11","kind":"disposition_to_issuer","acquired":false,"shares":22591,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock. 50% of the common shares underlying the restricted stock units vested on January 31, 2020 but settlement of such portion of the restricted stock units was delayed until transactions acceptable under the Issuer's insider trading policy were permitted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to the Reporting Person providing continuous service to the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to the Reporting Person providing continuous service to the Issuer through each such date."}],"balance_after":22590,"derivative":{"underlying":"Common Shares","underlying_shares":22591},"source":{"system":"sec-edgar","filing":"0001209191-20-036807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919120036807/doc4.xml","form_type":"4"}},{"id":3110667,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Common Shares","published_at":"2020-06-15T23:39:27.000Z","date":"2020-06-11","kind":"tax_withholding","acquired":false,"shares":9755,"price":3.09,"value":30142.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold on behalf of the Reporting Person in the open market to cover withholding taxes relating to the settlement of the vested restricted stock units."}],"balance_after":20336,"source":{"system":"sec-edgar","filing":"0001209191-20-036807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919120036807/doc4.xml","form_type":"4"}},{"id":3110666,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Common Shares","published_at":"2020-06-15T23:39:27.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":22591,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30091,"source":{"system":"sec-edgar","filing":"0001209191-20-036807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919120036807/doc4.xml","form_type":"4"}},{"id":3174271,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-04-18T00:59:48.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":112700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the restricted stock unit shall vest on April 15, 2021, April 15, 2022 and April 15, 2023, subject to the Reporting Person providing continuous service to the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third of the restricted stock unit shall vest on April 15, 2021, April 15, 2022 and April 15, 2023, subject to the Reporting Person providing continuous service to the Issuer through each such date."}],"balance_after":112700,"derivative":{"underlying":"Common Shares","underlying_shares":112700},"source":{"system":"sec-edgar","filing":"0001209191-20-025015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919120025015/doc4.xml","form_type":"4"}},{"id":3174270,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-18T00:59:48.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":169100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of four years with 25% of the common shares underlying the option vesting on April 15, 2021 and the remainder vesting in 12 equal quarterly installments thereafter, subject to Reporting Person providing continuous service to the Issuer on each such date.  The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."}],"balance_after":169100,"derivative":{"exercise_price":3.45,"expiration_date":"2030-04-14","underlying":"Common Shares","underlying_shares":169100},"source":{"system":"sec-edgar","filing":"0001209191-20-025015","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919120025015/doc4.xml","form_type":"4"}},{"id":3407123,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-09-24T21:14:55.000Z","date":"2019-09-21","kind":"grant","acquired":true,"shares":45181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to the Reporting Person providing continuous service to the Issuer through each such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the common shares underlying the restricted stock units vest on January 31, 2020 and the remainder vest on July 31, 2020, subject to the Reporting Person providing continuous service to the Issuer through each such date."}],"balance_after":45181,"derivative":{"underlying":"Common Shares","underlying_shares":45181},"source":{"system":"sec-edgar","filing":"0001636050-19-000084","document":"wf-form4_156935967895760.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000163605019000084/wf-form4_156935967895760.xml","form_type":"4"}},{"id":3487829,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-06-17T23:09:48.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":7500,"price":5.21,"value":39075.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.9798 to $5.35 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001209191-19-037525","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919119037525/doc4.xml","form_type":"4"}},{"id":3554009,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option ( Right to Buy)","published_at":"2019-04-18T01:14:21.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":1596000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares.  All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the option will vest at such time as the Issuer's 30-day trailing volume weighted average closing stock price (\"30-day VWAP\") is equal to $2.12; one-third of the option will vest at such time as the Issuer's 30-day VWAP stock price is equal to $4.24; and one-third of the option will vest at such time as the Issuer's 30-day VWAP stock price is equal to $6.36, in each case subject to the Reporting Person providing continuous service to the Issuer on each such date."}],"balance_after":1596000,"derivative":{"exercise_price":1.06,"expiration_date":"2029-04-14","underlying":"Common Stock","underlying_shares":1596000},"source":{"system":"sec-edgar","filing":"0001209191-19-025189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919119025189/doc4.xml","form_type":"4"}},{"id":3554008,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option ( Right to Buy)","published_at":"2019-04-18T01:14:21.000Z","date":"2019-04-15","kind":"grant","acquired":true,"shares":1596000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a period of four years, with one quarter of the common shares underlying the option vesting on April 15, 2020 and the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer on each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares.  All common shares underlying the option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."}],"balance_after":1596000,"derivative":{"exercise_price":1.06,"expiration_date":"2029-04-14","underlying":"Common Stock","underlying_shares":1596000},"source":{"system":"sec-edgar","filing":"0001209191-19-025189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919119025189/doc4.xml","form_type":"4"}},{"id":4055221,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":45996,"kind":"person","name":"Cheruvu Pavan","position":1,"cik":"0001731741","reported_name":"Cheruvu Pavan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-15T22:43:05.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":1940185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the common shares underlying the option will vest on February 11, 2019; the remainder vest in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan."}],"balance_after":1940185,"derivative":{"exercise_price":1.81,"expiration_date":"2028-02-12","underlying":"Common Shares","underlying_shares":1940185},"source":{"system":"sec-edgar","filing":"0001209191-18-010478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1731741/000120919118010478/doc4.xml","form_type":"4"}}]}